Cyteir Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cyteir Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cyteir Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cyteir Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $376 | 124 | 3.04 |
| 2023-09-30 | $1.4k | 496 | 2.84 |
| 2023-06-30 | $1.3k | 496 | 2.60 |
| 2023-03-31 | $999 | 496 | 2.02 |
| 2022-12-31 | $999 | 496 | 2.02 |
| 2022-06-30 | $4.0k | 1.4k | 2.82 |
| 2022-03-31 | $49k | 13k | 3.77 |
| 2021-12-31 | $71k | 6.3k | 11.24 |
Top funds holding Cyteir Therapeutics
View all funds holding Cyteir Therapeutics